Jiang Zhu

2.7k total citations · 1 hit paper
73 papers, 1.4k citations indexed

About

Jiang Zhu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jiang Zhu has authored 73 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 21 papers in Surgery. Recurrent topics in Jiang Zhu's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Head and Neck Cancer Studies (9 papers). Jiang Zhu is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Head and Neck Cancer Studies (9 papers). Jiang Zhu collaborates with scholars based in China, United States and Germany. Jiang Zhu's co-authors include Kenneth J. Barr, Shen Wang, Stig K. Hansen, Mike Randal, Robert S. McDowell, Min Zhong, Daniel A. Erlanson, Christian Wiesmann, Lisa J. Taylor and Mei Hou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Jiang Zhu

65 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironment

2025 24 citations Tian Lan, Fengwei Gao et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiang Zhu China	20	708	353	344	263	213	73	1.4k
Bingyin Shi China	25	1.1k 1.5×	342 1.0×	232 0.7×	150 0.6×	190 0.9×	87	1.9k
Antonino Grassadonia Italy	23	520 0.7×	570 1.6×	169 0.5×	302 1.1×	101 0.5×	71	1.4k
Dapeng Wu China	24	903 1.3×	481 1.4×	307 0.9×	201 0.8×	133 0.6×	88	1.8k
Ji Nie China	10	748 1.1×	327 0.9×	232 0.7×	92 0.3×	101 0.5×	12	1.3k
Francesca Maddalena Italy	25	1.3k 1.8×	397 1.1×	180 0.5×	106 0.4×	132 0.6×	50	1.8k
Ernest Han United States	24	557 0.8×	468 1.3×	210 0.6×	131 0.5×	305 1.4×	95	1.5k
Xiaoying Sun China	20	663 0.9×	787 2.2×	259 0.8×	376 1.4×	201 0.9×	50	1.6k
Lisa M. Schumaker United States	24	912 1.3×	702 2.0×	264 0.8×	121 0.5×	481 2.3×	44	2.4k
Amir Mortazavi United States	25	658 0.9×	621 1.8×	455 1.3×	190 0.7×	573 2.7×	108	1.7k

Countries citing papers authored by Jiang Zhu

Since Specialization

Citations

This map shows the geographic impact of Jiang Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang Zhu more than expected).

Fields of papers citing papers by Jiang Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang Zhu. The network helps show where Jiang Zhu may publish in the future.

Co-authorship network of co-authors of Jiang Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang Zhu. A scholar is included among the top collaborators of Jiang Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang Zhu. Jiang Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Jiang, Chee Khoon Lee, Isamu Okamoto, et al.. (2025). LBA77 FLAURA2: Exploratory overall survival (OS) analysis in patients (pts) with poorer prognostic factors treated with osimertinib (osi) ± platinum-pemetrexed chemotherapy (CTx) as first-line (1L) treatment (tx) for EGFR-mutated (EGFRm) advanced NSCLC. Annals of Oncology. 36. S1618–S1619.

Xu, Xiangxiang, et al.. (2025). GSH-activable and cytolytic iPep-coupled immune nanoagonist for cancer synergetic therapy. Biomaterials. 322. 123402–123402. 1 indexed citations

Lan, Tian, Fengwei Gao, Yunshi Cai, et al.. (2025). The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironment. Nature Communications. 16(1). 333–333. 24 indexed citations breakdown →

Yan, Chao-Qun, et al.. (2024). Prediction for post-ERCP pancreatitis in non-elderly patients with common bile duct stones: a cross-sectional study at a major Chinese tertiary hospital (2015–2023). BMC Medical Informatics and Decision Making. 24(1). 143–143. 3 indexed citations

Zheng, Jinxin, et al.. (2024). Interpretable machine learning for predicting chronic kidney disease progression risk. Digital Health. 10. 589867937–589867937. 17 indexed citations

Zhu, Jiang, Denghui Wang, Chang Liu, et al.. (2023). Development and validation of a new prognostic immune–inflammatory–nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study. Frontiers in Immunology. 14. 1165510–1165510. 31 indexed citations

Wang, Zhihai, et al.. (2023). Prognostic analysis of surgical treatment for T3 glottic laryngeal cancer based on different tumor extension patterns. European Archives of Oto-Rhino-Laryngology. 281(3). 1379–1389. 2 indexed citations

Zhu, Jiang, Rui Huang, Ping Yü, Haoyu Ren, & Xinliang Su. (2022). Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma. International Journal of Endocrinology. 2022. 1–9. 7 indexed citations

Zhu, Jiang, Rui Huang, Ping Yü, et al.. (2021). Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma. Gland Surgery. 10(1). 73–82. 11 indexed citations

10.

Huang, Rui, et al.. (2021). The effect of programmed intermittent epidural bolus compared with continuous epidural infusion in labor analgesia with ropivacaine: a meta-analysis of randomized controlled trials. Annals of Palliative Medicine. 10(3). 2408–2420. 9 indexed citations

11.

Zhu, Jiang, et al.. (2020). Expression of lncRNA MSC-AS1 in hepatocellular carcinoma cell lines and its effect on proliferation, apoptosis, and migration. The Turkish Journal of Gastroenterology. 31(12). 860–867. 4 indexed citations

12.

Chen, Qi, et al.. (2020). LncRNA MCM3AP-AS1 promotes breast cancer progression via modulating miR-28-5p/CENPF axis. Biomedicine & Pharmacotherapy. 128. 110289–110289. 45 indexed citations

13.

Yu, Min, Qian Zhao, Yanying Li, et al.. (2018). Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor. Cancer Biotherapy and Radiopharmaceuticals. 33(10). 421–426. 6 indexed citations

14.

Dai, Zhenyu, et al.. (2016). [Endovascular implantation of iodine-125 seeds strand and portal vein stenting followed by transcatheter arterial chemoembolization combined therapy with sorafenib for hepatocellular carcinoma with main portal vein tumor thrombus].. PubMed. 96(23). 1838–42. 5 indexed citations

15.

Zhou, Lin, Yongmei Liu, Yu Qin, et al.. (2016). Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation study. Lung Cancer. 96. 93–100. 26 indexed citations

16.

Li, Tao, Yongmei Liu, Na Li, et al.. (2015). Concurrent paclitaxel-based chemo-radiotherapy for post-surgical microscopic residual tumor at the bronchial margin (R1 resection) in non-small-cell lung cancer. BMC Cancer. 15(1). 36–36. 6 indexed citations

17.

Zhu, Jiang, et al.. (2015). [Laryngeal and tracheal stenosis caused by Wegener's granulomatosis].. PubMed. 29(9). 862–4. 2 indexed citations

18.

Gong, Rongpeng, Yanping Gong, Jinming Yang, et al.. (2013). Efficient detection of the V600E mutation of the BRAF gene in papillary thyroid carcinoma using multiplex allele-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography. Genetics and Molecular Research. 12(4). 4990–4997. 2 indexed citations

19.

Zhu, Jiang, Yan Wang, Mei Hou, Hui Li, & Jie Zhang. (2007). Imatinib Mesylate Treatment for Advanced Gastrointestinal Stromal Tumor: A Pilot Study Focusing on Patients Experiencing Sole Liver Metastasis after a Prior Radical Resection. Oncology. 73(5-6). 324–327. 8 indexed citations

20.

Zhu, Jiang, et al.. (2003). [A study on the application of Nickle-Titanium alloys stent for prevention and treatment tracheostomal stenosis after total laryngectomy].. PubMed. 17(8). 476–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact